XE
Xeris Biopharma
XERS·NASDAQChicago ILFounded 2005300 employees
Small CapbiotechPublicEndocrinologyRare Disease
Platform: Gvoke Glucagon
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (XERS)
Loading XERS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemazanubrutinib | XER-7677 | Phase 1/2 | 2 | TYK2 | NarcolepsyRB | ||
| XER-568 | XER-568 | Phase 1 | 1 | Aβ | PsoriasisAML |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)